Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 No reactivation of JCV in bone marrow of follicular lymphoma patients treated front-line with rituximab plus 90y-ibritumomab tiuxetan.

× No keyword cloud information.

5 in total

1. The role of bone marrow cells for JCV pathogenicity.

Authors: Daniele Focosi; Fabrizio Maggi; Elisabetta Andreoli; Letizia Lanini; Luca Ceccherini-Nelli; Mario Petrini
Journal: J Clin Virol Date: 2009-06-07 Impact factor: 3.168

2. Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.

Authors: Marco Tuccori; Daniele Focosi; Corrado Blandizzi; Matteo Pelosini; Sabrina Montagnani; Fabrizio Maggi; Mauro Pistello; Luca Antonioli; Matteo Fornai; Pasquale Pepe; Giuseppe Rossi; Mario Petrini
Journal: Oncologist Date: 2010-11-01

3. Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.

Authors: Adalberto Ibatici; Gian Matteo Pica; Sandro Nati; Umberto Vitolo; Barbara Botto; Chiara Ciochetto; Mario Petrini; Sara Galimberti; Elena Ciabatti; Enrico Orciuolo; Pier Luigi Zinzani; Nicola Cascavilla; Fabio Guolo; Giulio Fraternali Orcioni; Angelo M Carella
Journal: Br J Haematol Date: 2013-12-17 Impact factor: 6.998

4. JC viremia in natalizumab-treated patients with multiple sclerosis.

Authors: Eugene O Major; Elliot Frohman; Daniel Douek
Journal: N Engl J Med Date: 2013-06-06 Impact factor: 91.245

5. Asymptomatic reactivation of JC virus in patients treated with natalizumab.

Authors: Yiping Chen; Evelyn Bord; Troy Tompkins; Janice Miller; Chen S Tan; R Philip Kinkel; Marion C Stein; Raphael P Viscidi; Long H Ngo; Igor J Koralnik
Journal: N Engl J Med Date: 2009-09-10 Impact factor: 91.245

5 in total